// App-Quantinova.ai

3973 : Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Optimize the Indication of Stem Cell Transplantation and Cranial Irradiation: Results of Japan Association Childhood Leukemia Study Group (JACLS) Protocol ALL-02

Researchers

Presenter

  • Daiichiro Hasegawa

Principal Investigators

  • Keiko Yagi

  • Koji Kato

  • Yoshiyuki Kosaka

  • Yoshihiro Komada

  • Akihiro Iguchi

  • Hirohide Kawasaki

  • Hiroki Hori

  • Atsushi Sato

  • Tooru Kudo

  • Tatsutoshi Nakahata

  • Megumi Oda

  • Yoshihiro Takahashi

  • Junichi Hara

  • Keizo Horibe

  • Ikuya Usami

  • So-ichi Suenobu

  • Nishimura Shinichiro

  • Nobuhiro Suzuki

  • Yoshiko Hashii

  • Takao Deguchi

  • Akiko M. Saito

Medical Centers

  • Center for iPS Research and Application, Kyoto University, Kyoto, Japan.

  • Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Department of Pediatric Hematology/Onology, Okayama University, Okayama, Japan

  • Department of Paediatric Hematology/Oncology, Miyagi Children's Hospital, Sendai, Japan

  • Department of Hematology and Oncology, Shizuoka Childrens Hospital, Shizuoka, Japan

  • Department of Thoracic Oncology, Kansai Medical University Hirakata Hospital, Osaka, Japan

  • Hokkaido Medical Center for Child Health and Rehabilitation, Sapporo, Japan

  • Division of General Pediatrics and Emergency Medicine, Department of Pediatrics, Oita University Faculty of Medicine, Yufu, Japan

  • Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan

  • Clinical Rsch Cntr, National Hosp Organization, Nagoya Med Cntr, Nagoya, Japan

  • Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

  • Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan

  • Department of Surgery, Aomori Prefectural Central Hospital, Aomori, Japan

  • Department of Medical Oncology,Osaki Citizen Hospital, Osaki-Shi, Japan

  • Hokkaido University Hospital, Sapporo, Japan

  • Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

  • The Japan Association of Childhood Leukemia Study, Osaka, Japan

  • Department of Hematology and Oncology, Childrens Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya,

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Philadelphia chromosome–positive (Ph+) ALL

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Progesterone receptor

Drug/Treatment

  • Methotrexate

  • Prednisolone

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved